Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Cannabis-derived MS drug filed for European approval

May 20, 2009 Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …
News

EFPIA plans counterfeit crackdown

May 20, 2009 Manufacturing and Production, Research and Development EFPIA, counterfeits

 European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …
News

SkyePharma cuts staff at French and Swiss facilities

May 20, 2009 Research and Development, Sales and Marketing Skyepharma

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …
News

The medical-marketing interface and how to bridge the gap

May 18, 2009 Research and Development, Sales and Marketing marketing, medical

Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …
Feature

GSK signs oncology deal with UK biotech

May 18, 2009 Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …
News

Sanofi-Aventis signs deal with Japanese biotech

May 15, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …
News

Kendle trims down as profits slump

May 15, 2009 Research and Development Kendle

Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …
News

Boehringer signs diabetes and obesity deal

May 14, 2009 Research and Development, Sales and Marketing Boehringer

Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …
News

Kennedy sets out views on NICE’s future

May 14, 2009 Research and Development NICE

Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …
News

AstraZeneca buoyed as Brilinta tops Plavix in trial

May 13, 2009 Research and Development, Sales and Marketing AZ, Brillinta

AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …
News

UK a step closer to new swine flu vaccine

May 11, 2009 Research and Development NHS, h1n1

The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …
News

GSK claims superiority for Cervarix in head-to-head trial

May 11, 2009 Research and Development, Sales and Marketing GSK, vaccines

GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
News

Cmed and Tessella join forces on adaptive trials

May 11, 2009 Research and Development Cmed, digi

UK contract research organisation Cmed Research has bolstered its ability to carry out adaptive clinical trials on behalf of clients …
News

Pharma must go further with its collaborations

May 8, 2009 Research and Development, Sales and Marketing pwC, strategy

Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …
News

Servier signs drug discovery deal with Vernalis

May 7, 2009 Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026